Trifunctional molecule and application thereof
AssigneeCytocares (Shanghai) Inc.
InventorsShuai Chen, Huaxing Zhu, Yuanping Liao
Life of this patent
Estimating the term…
Loading patent…
AssigneeCytocares (Shanghai) Inc.
InventorsShuai Chen, Huaxing Zhu, Yuanping Liao
Estimating the term…
This disclosure belongs to the field of biomedical technology, and particularly refers to a trifunctional molecule and the application thereof. The structure of the trifunctional molecule includes a first functional domain, a second functional domain and a third functional domain. These domains are capable of simultaneously binding to CD19, CD3, and T cell positive (negative) costimulatory factors, thereby producing the first and second signal required for T cell activation. The trifunctional molecule is a recombinant protein peptide chain, which can be produced by a eukaryotic cell expression system. The product has a single structure, simple purification process, high protein yield, and preparation process and product stability. The trifunctional molecule is superior to the anti-CD19/anti-CD3 BiTE bispecific antibody in killing CD19-positive target cells. Compared with the CAR-T technology targeting CD19, the trifunctional molecule is more convenient to use, the dose is controllable, and the side effects of CAR-T are avoided.
A trifunctional molecule, selected from any one of the following:
Dependencies are inferred from the claim text.